Population
Patients with advanced cardiac disease transitioning from active to less aggressive treatment goals
Design
Review
Authors
Loading...
Clinicians must integrate ethical-legal frameworks into withdrawal decisions; leaves open standardized protocols and outcome studies in advanced cardiac disease.
Highlights the ethical, legal, and clinical considerations for withdrawing life-sustaining cardiac therapies in patients with advanced cardiac disease.
Wiegand et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: